HALOZYME THERAPEUTICS INC (HALO)       57.85  +0.11 (+0.19%)

57.85  +0.11 (+0.19%)

US40637H1095 - Common Stock - After market: 57.85 0 (0%)

TTM
(2022-9-30)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
2018
(2018-12-31)
Revenue
580.62M443.31M267.60M196.00M151.90M
Non Recurring Items
-23.21M-20.96MN/AN/AN/A
Cost Of Goods
118.77M81.41M43.40M45.50M10.10M
Gross Profit
461.85M361.90M224.20M150.40M141.70M
Operating Expenses
191.80M86.00M79.90M218.10M211.10M
Operating Income
270.06M275.90M144.30M-67.70M-69.40M
Interest Expense
-13.91M-6.42M-15.00M-4.60M-10.50M
Income Before Taxes
232.94M248.52M129.30M-72.30M-79.80M
Income Tax
21.74M-154.19M200.00K0.00500.00K
Net Income
211.20M402.71M129.10M-72.20M-80.30M
EBITDA
313.36M278.90M147.60M-63.60M-67.00M
 
Per Share Data
EPS Diluted Total Ops
1.492.740.91-0.50-0.56
Non GAAP EPS
2.161.920.90-0.50-0.55
 
Statistics
Gross Profit Margin
79.54%81.64%83.78%76.73%93.29%
Profit Margin
36.37%90.84%48.24%-36.84%-52.86%
Operating Profit Margin
46.51%62.24%53.92%-34.54%-45.69%

All data in USD

Charts